Search results
The ownership structure of Haleon PLC (GB:HLN) stock is a mix of institutional, retail and individual investors. Approximately 20.62% of the company’s stock is owned by Institutional Investors, 0.02% is owned by Insiders and 79.36% is owned by Public Companies and Individual Investors.
HALEON PLC HLN Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.
4 days ago · Company profile for Haleon plc (HLN) with a description, list of executives, contact details and other key facts.
- United Kingdom
- Drug Manufacturers-Specialty & Generic
- 2022
- Healthcare
May 3, 2024 · Key Insights. Significantly high institutional ownership implies Haleon's stock price is sensitive to their trading actions. A total of 11 investors have a majority stake in the company with 51%...
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6] Sir David Lewis is chairman, with Brian McNamara as CEO. [7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange.
Oct 10, 2024 · The company's largest shareholder is Pfizer Inc., with ownership of 15%. For context, the second largest shareholder holds about 11% of the shares outstanding, followed by an ownership of 5.2%...
People also ask
Who owns haleon plc (HLN)?
Who owns haleon stock?
Who bought Lamisil & ChapStick?
Sir David Lewis is chairman, with Brian McNamara as CEO. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock...